At this conference that AKSY is presenting at I am sure they will continue to tout the benefits of daily dialysis. In-center hemo only adds to the woes and ill health of the people that are on it. Too much research has shown that more dialysis is better and daily dialysis does provide this. Also the cardiovasculare risks associated with regular in-center hemo is disturbing when all that would be required would be to dialyze every day. That is why this new system will work well for certain portion of the population. Now what all this has to do with the price of the stock except that those mfs closed it below 5 is beyond me. Keep the change you filthy animals.